These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 9337529
1. Cancer procoagulant--CP. Rucińska M, Gacko M, Skrzydlewski Z. Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529 [Abstract] [Full Text] [Related]
3. [Cancer procoagulant (CP): the new biochemical marker in oncologic diagnosis]. Kozuszko B, Skrzydlewska E, Skrzydlewski Z. Pol Merkur Lekarski; 2000 Jun; 8(48):416-9. PubMed ID: 10967923 [Abstract] [Full Text] [Related]
4. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue. Gordon SG, Mielicki WP. Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049 [Abstract] [Full Text] [Related]
5. New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors. Mielicki WP, Tagawa M, Gordon SG. Thromb Haemost; 1994 Apr; 71(4):456-60. PubMed ID: 8052963 [Abstract] [Full Text] [Related]
6. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker. Gordon SG, Cross BA. Cancer Res; 1990 Oct 01; 50(19):6229-34. PubMed ID: 2169340 [Abstract] [Full Text] [Related]
7. [Intravascular blood coagulation and its role in malignant neoplasms]. Pavlovskiĭ DP. Vopr Onkol; 1981 Oct 01; 27(7):96-103. PubMed ID: 7023043 [No Abstract] [Full Text] [Related]
8. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro. Kaplinska K, Rozalski M, Krajewska U, Mielicki WP. Thromb Res; 2009 Jul 01; 124(3):364-7. PubMed ID: 19419757 [Abstract] [Full Text] [Related]
9. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease]. Kamocka M, Mielicki WP. Postepy Biochem; 2003 Jul 01; 49(3):168-74. PubMed ID: 15083609 [No Abstract] [Full Text] [Related]
10. A factor X-activating cysteine protease from malignant tissue. Gordon SG, Cross BA. J Clin Invest; 1981 Jun 01; 67(6):1665-71. PubMed ID: 7016920 [Abstract] [Full Text] [Related]
13. Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. Donati MB. Thromb Haemost; 1995 Jul 01; 74(1):278-81. PubMed ID: 8578472 [Abstract] [Full Text] [Related]
14. Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma. Roncaglioni MC, Falanga A, D'Alessandro AP, Alessio MG, Casali B, Donati MB. Haematologica; 1989 Jul 01; 74(2):143-7. PubMed ID: 2501168 [Abstract] [Full Text] [Related]
15. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum. Rucińska M, Furman M, Skrzydlewski Z, Zaremba E. Acta Biochim Pol; 1997 Jul 01; 44(1):109-12. PubMed ID: 9241361 [Abstract] [Full Text] [Related]
18. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues. Kaplinska K, Mielicki WP. Blood Coagul Fibrinolysis; 2009 Jul 01; 20(5):315-20. PubMed ID: 19448531 [Abstract] [Full Text] [Related]